Ovid Therapeutics Inc. (OVID) Net income 2016–2025
Ovid Therapeutics Inc. (OVID) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$17.4MFY2025 · since FY2016: -$22.4M → -$17.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$17.4M | +34.1% |
| FY2024 | -$26.4M | +49.5% |
| FY2023 | -$52.3M | +3.4% |
| FY2022 | -$54.2M | -144.1% |
| FY2021 | $122.8M | +251.6% |
| FY2020 | -$81.0M | -34.0% |
| FY2019 | -$60.5M | -16.3% |
| FY2018 | -$52.0M | +19.8% |
| FY2017 | -$64.8M | -189.1% |
| FY2016 | -$22.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice